Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Maximilian Baumgartner"'
Autor:
Elisabeth Orgler, Maximilian Baumgartner, Stefanie Duller, Christina Kumptisch, Bela Hausmann, Doris Moser, Vineeta Khare, Michaela Lang, Thomas Köcher, Adrian Frick, Markus Muttenthaler, Athanasios Makristathis, Christine Moissl-Eichinger, Christoph Gasche
Publikováno v:
Gut Microbes, Vol 16, Iss 1 (2024)
The gut microbiota has been implicated as a driver of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Recently we described, mucosal biofilms, signifying alterations in microbiota composition and bile acid (BA) metabolism in IBS
Externí odkaz:
https://doaj.org/article/26bffac2a9eb40418a42c4ac2a5d1048
Autor:
Claudia D. Fuchs, Thierry Claudel, Veronika Mlitz, Alessandra Riva, Moritz Menz, Ksenia Brusilovskaya, Felix Haller, Maximilian Baumgartner, Philipp Königshofer, Lukas W. Unger, Wilhelm Sjöland, Hubert Scharnagl, Tatjana Stojakovic, Georg Busslinger, Thomas Reiberger, Hanns-Ulrich Marschall, Michael Trauner
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 16, Iss 5, Pp 847-856 (2023)
Background & Aims: Glucagon-like peptide (GLP)-2 may exert antifibrotic effects on hepatic stellate cells (HSCs). Thus, we aimed to test whether application of the GLP-2 analogue teduglutide has hepatoprotective and antifibrotic effects in the Mdr2/A
Externí odkaz:
https://doaj.org/article/38608f1e5ab54160be285257cf74e3a7
Autor:
Maximilian Baumgartner, Rebecca Zirnbauer, Sabine Schlager, Daniel Mertens, Nikolaus Gasche, Barbara Sladek, Craig Herbold, Olga Bochkareva, Vera Emelianenko, Harald Vogelsang, Michaela Lang, Anton Klotz, Birgit Moik, Athanasios Makristathis, David Berry, Stefanie Dabsch, Vineeta Khare, Christoph Gasche
Publikováno v:
Gut Microbes, Vol 14, Iss 1 (2022)
With increasing urbanization and industrialization, the prevalence of inflammatory bowel diseases (IBDs) has steadily been rising over the past two decades. IBD involves flares of gastrointestinal (GI) inflammation accompanied by microbiota perturbat
Externí odkaz:
https://doaj.org/article/6c622a81435d41d681ded58696d4847d
Autor:
Rayko Evstatiev, Adam Cervenka, Tina Austerlitz, Gunther Deim, Maximilian Baumgartner, Andrea Beer, Anita Krnjic, Christina Gmainer, Michaela Lang, Adrian Frick, Helga Schachner, Vineeta Khare, Christoph Gasche
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Inflammatory bowel disease is a group of conditions with rising incidence caused by genetic and environmental factors including diet. The chelator ethylenediaminetetraacetate (EDTA) is widely used by the food and pharmaceutical industry amon
Externí odkaz:
https://doaj.org/article/c870e4f379f74efaa91213d474882b21
Autor:
Adrian Frick, Vineeta Khare, Kristine Jimenez, Kyle Dammann, Michaela Lang, Anita Krnjic, Christina Gmainer, Maximilian Baumgartner, Ildiko Mesteri, Christoph Gasche
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 11, Iss 3, Pp 892-907.e1 (2021)
Background & Aims: p21-activated kinase-1 (PAK1) belongs to a family of serine-threonine kinases and contributes to cellular pathways such as nuclear factor-κB (NF-κB), mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase/protein
Externí odkaz:
https://doaj.org/article/709ac4fc74d24866bd6d4548848d2c7b
Autor:
Charlotte Gröschel, Maximilian Prinz-Wohlgenannt, Ildiko Mesteri, Sobha Karuthedom George, Lena Trawnicek, Denise Heiden, Abhishek Aggarwal, Samawansha Tennakoon, Maximilian Baumgartner, Christoph Gasche, Michaela Lang, Rodrig Marculescu, Teresa Manhardt, Martin Schepelmann, Enikö Kallay
Publikováno v:
Nutrients, Vol 12, Iss 1, p 45 (2019)
Inflammatory bowel disease increases the odds of developing colitis-associated cancer. We hypothesized that Western-style diet (WD) aggravates azoxymethane (AOM)/dextran sulfate sodium salt (DSS)-induced colitis-associated tumorigenesis and that swit
Externí odkaz:
https://doaj.org/article/e26003a254914e788f27c1dfe9089c4b
Autor:
Maximilian, Baumgartner, Rebecca, Zirnbauer, Sabine, Schlager, Daniel, Mertens, Nikolaus, Gasche, Barbara, Sladek, Craig, Herbold, Olga, Bochkareva, Vera, Emelianenko, Harald, Vogelsang, Michaela, Lang, Anton, Klotz, Birgit, Moik, Athanasios, Makristathis, David, Berry, Stefanie, Dabsch, Vineeta, Khare, Christoph, Gasche
Publikováno v:
Gut microbes. 14(1)
With increasing urbanization and industrialization, the prevalence of inflammatory bowel diseases (IBDs) has steadily been rising over the past two decades. IBD involves flares of gastrointestinal (GI) inflammation accompanied by microbiota perturbat
Autor:
Adrian Frick, Adam Cervenka, Andrea Beer, Maximilian Baumgartner, Rayko Evstatiev, Anita Krnjic, Christoph Gasche, Gunther Deim, Christina Gmainer, Helga Schachner, Michaela Lang, Tina Austerlitz, Vineeta Khare
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports
Scientific Reports
Inflammatory bowel disease is a group of conditions with rising incidence caused by genetic and environmental factors including diet. The chelator ethylenediaminetetraacetate (EDTA) is widely used by the food and pharmaceutical industry among numerou
Autor:
Anita Krnjic, Vineeta Khare, Maximilian Baumgartner, Ildiko Mesteri, Christoph Gasche, Kyle Dammann, Adrian Frick, Kristine Jimenez, Christina Gmainer, Michaela Lang
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 11, Iss 3, Pp 892-907.e1 (2021)
Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology
Background & Aims p21-activated kinase-1 (PAK1) belongs to a family of serine-threonine kinases and contributes to cellular pathways such as nuclear factor-κB (NF-κB), mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase/protein k
Autor:
Ci Zhu, Nicole Boucheron, Ramona Rica, Valentina Stolz, Emina Halilbasic, Thierry Claudel, Osamah Al-Rubaye, Alexander Lercher, Maximilian Baumgartner, Lisa Sandner, Teresa Preglej, Marlis Alteneder, Veronika Mlitz, Claudia D. Fuchs, Daniela Hainberger, Jelena Remetic, Anna Ohradanova-Repic, Philipp Schatzlmaier, Tatjana Stojakovic, Hubert Scharnagl, Shinya Sakaguchi, Andreas Bergthaler, Hannes Stockinger, Wilfried Ellmeier, Michael Trauner
Objective24-Nor-ursodeoxycholic acid (NorUDCA) is a novel therapeutic bile acid for treating primary sclerosing cholangitis (PSC), an immune-mediated cholestatic liver disease. Since PSC strongly associates with inflammatory bowel diseases (IBD) driv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8263ba9277e30708557ec5cfc1446399
https://doi.org/10.1101/2022.02.10.479975
https://doi.org/10.1101/2022.02.10.479975